Gentisic acid
|
Basic information |
| Metabolite name | Gentisic acid |
 | HMDB0000152 |
 |
C00628 |
 |
3469 |
| Synonyms | NA |
| No. of studies | 8 |
|
Basic information |
| Metabolite name | Gentisic acid |
| HMDB0000152 |
|
C00628 |
|
3469 |
| Synonyms | NA |
| No. of studies | 8 |
|
Relationship between Gentisic acid and depression (count: 8) |
| Study | Study Type  |
Comparison groups | Tissue | Organism | Up/Down regulated |
| Study M1061 | Type1 | CUMS group vs. control group | Faece | Sprague-Dawley rat | Down |
| Study M204 | Type1 | LPS group vs. control group | Hypothalamus | CD-1 mouse | Down |
| Study M571 | Type1 | LPS group vs. control group | Hypothalamus | CD-1 mouse | Down |
| Study M686 | Type1 | depression group vs. control group | Urine | Human | Down |
| Study M806 | Type1 | CUMS group vs. control group | Urine | C57BL/6 mouse | Down |
| Study M806 | Type2 | corticosterone + taxifolin spina group vs. corticosterone group | Urine | C57BL/6 mouse | Up |
| Study M898 | Type1 | end-stage renal disease with depression group vs. end-stage renal disease without depression group | Serum | Human | Up |
| Study M905 | Type1 | subclinical depression group vs. control group | Urine | Human | Down |
| Study M953 | Type2 | CRS + Shugan Granule group vs. CRS group | Faece | Sprague-Dawley rat | Down |